The race to develop treatments and a vaccine for COVID-19 highlights the value of repurposing solutions.
There are four common misconceptions that leaders often succumb to when thinking about disruptive innovation.
Scott D. Anthony, Michael Putz, and Paul Michelman
Even before the COVID-19 pandemic, traditional education models were poised to be disrupted.
Michael B. Horn and Karen Dillon
Tucker Marion and Sebastian Fixson outline four essential skills workers need to master to succeed in digital environments.
Tucker J. Marion, Sebastian K. Fixson, and Paul Michelman
To ensure success, entrepreneurs need to create two business plans: one for disruption and one for cooperation.
Joshua Gans and Karen Dillon
Amy Webb outlines the 11 sources of change that could disrupt your organization.
Amy Webb and Paul Michelman
SAP’s Max Wessel explains why advisory board guidance is critical in innovation.
Max Wessel and Karen Dillon
The current pandemic presents an opportunity for creativity to rethink skills development, worker protections, and health care.
Rita Gunther McGrath and Paul Michelman
Western organizations shouldn’t attempt to transplant what works in their own countries into developing economies, but instead should become familiar with the environments there and seize existing opportunities in-context.
Karen Dillon, Efosa Ojomo, and Paul Michelman
To launch successful products that delight customers, companies need a new approach to data analytics.
Barbara H. Wixom, Ronny M. Schüritz, and Killian Farrell
Companies must think critically about how to address the issue of technology access and inequity throughout the COVID-19 crisis.
Lesley Chiou and Catherine Tucker
Swarm systems draw input from individuals and use algorithms to optimize system performance in real time.
Mark Purdy, Ray Eitel-Porter, and Max Klymenko
Amid pandemic-driven market changes, opportunities await organizations that proactively adjust their business strategies.
Michael Wade and Heidi Bjerkan
Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.